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ABSTRACT
ANCHOR is a web-based tool whose aim is to facili-
tate the analysis of protein–protein interfaces with
regard to its suitability for small molecule drug
design. To this end, ANCHOR exploits the
so-called anchor residues, i.e. amino acid side-
chains deeply buried at protein–protein interfaces,
to indicate possible druggable pockets to be
targeted by small molecules. For a given protein–
protein complex submitted by the user, ANCHOR
calculates the change in solvent accessible
surface area ("SASA) upon binding for each
side-chain, along with an estimate of its contribu-
tion to the binding free energy. A Jmol-based tool
allows the user to interactively visualize selected
anchor residues in their pockets as well as the
stereochemical properties of the surrounding
region such as hydrogen bonding. ANCHOR
includes a Protein Data Bank (PDB) wide database
of pre-computed anchor residues from more than
30000 PDB entries with at least two protein
chains. The user can query according to amino
acids, buried area (SASA), energy or keywords
related to indication areas, e.g. oncogene or
diabetes. This database provides a resource to
rapidly assess protein–protein interactions for the
suitability of small molecules or fragments with
bioisostere anchor analogues as possible com-
pounds for pharmaceutical intervention. ANCHOR
web server and database are freely available at
http://structure.pitt.edu/anchor.
INTRODUCTION
Protein–protein interactions (PPIs) are attractive targets
for pharmaceutical intervention (1–5) because their
ubiquitous role in mediating biological processes in the
cell and the fact that many diseases such as cancer can
be attributed to malfunctioning PPIs (6–8). The ability
to modulate speciﬁc PPIs with small organic molecules
for therapeutic applications has therefore been pursued
by the scientiﬁc community, who faces the challenging
task of discovering and/or designing small molecules
that bind with high aﬃnity to relatively large and ﬂat
protein–protein interfaces.
Despite the fact that proteins often interact through
large contact surfaces, the presence of well-deﬁned
‘anchor’ sites and cavities which when ﬁlled with the ap-
propriate compound might trigger a strong attraction
between receptor and ligand (9,10) allows medicinal
chemists to focus on targeting these areas. Alanine
scanning mutagenesis has been extensively used to detect
the amino acid residues that contribute to the binding free
energy of a given PPI (11–13). In addition, a large number
of computational methods have been developed to predict
‘hotspots’, i.e. those residues that result in signiﬁcant loss
of binding aﬃnity when mutated to alanine
(G>2.0kcal/mol) (14–18), making use of the wealth
of experimental data available from alanine substitution
studies to train their models. However, few studies have
focused exclusively on anchor sites (10), which contrary to
hotspots have an explicit concave/convex geometry ap-
pealing for pharmaceutical intervention.
The identiﬁcation of anchor residues in PPIs is very
useful not only to provide insights into mechanisms of
protein–protein recognition, but also to indicate the
areas to be targeted with small molecules. Here, we
report the development of ANCHOR, a web-based tool
created to facilitate the analysis of PPI druggable cavities.
For a given protein–protein complex submitted by the
user, ANCHOR calculates the change in solvent accessible
surface area (SASA) upon binding for each side-chain,
along with an estimate of its contribution to the binding
free energy (19,20). A Jmol-based tool allows the user to
interactively visualize selected anchor residues in their
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surrounding region such as hydrogen bonding and
charge–charge interactions. Moreover, ANCHOR
includes a database of pre-computed anchor residues
from more than 30000 Protein Data Bank (PDB) (21)
entries with multiple protein chains. The user can query
the database according to amino acids, buried area
(SASA), energy or keywords related to indication
areas, e.g. oncogene or diabetes. These queries could be
useful to rapidly screen for suitable sites/cavities that ﬁt
fragments with chemical properties similar to anchor
residues, correlating targets with functional categories or
diseases. ANCHOR is complementary to existing tools for
interface analysis of proteins reviewed recently (22).
MATERIALS AND METHODS
Characterization of anchor residues
For a given protein–protein complex structure, ANCHOR
performs the following calculations:
(i) Add missing atoms including polar hydrogen using
CHARMM19 (23) and perform a small round of
hydrogen minimization to optimize hydrogen
bonding.
(ii) Calculate the change in solvent-accessible surface
area upon binding for each residue’s side-chain
i (SASAi; C-alpha included) by computing the
diﬀerence in SASA of the side-chain in the
unbound protein (isolated from complex) and
in the bound protein complex: SASAi ¼
SASAunbound
i   SASAbound
i . SASAi is calculated
with NACCESS (Hubbard and Thornton,
‘NACCESS’, Computer Program, 1993) using
default parameters and a 1.4A ˚ water radius. The
user can specify the chains that comprise the
receptor and ligand or choose the default settings,
in which case the value of SASAi is obtained for
every residue of each individual protein chain
(unbound) against all the others (bound).
(iii) Estimate the associated binding free energy of each
residue using FastContact (19,20), a fast empirical
pairwise estimate that combines a standard
distance-dependent dielectric ‘4r’ electrostatic and
a desolvation contact potential (24). FastContact
has been successfully applied in protein-protein
docking (25,26) and for scoring diﬀerent sets of
docked conformations (20).
(iv) Output is the values of SASA and FastContact
energy for each residue.
Database and query engine
We applied the procedure described above to construct a
database of pre-computed anchor residues from 30737
PDB entries with at least two protein chains (but no
DNA/RNA chains). For NMR structures, we used the
ﬁrst NMR model deposited in the PDB as a representative
structure of the NMR ensemble. Since anchor residues are
constrained on the protein–protein interface, the results
do not change signiﬁcantly by using a diﬀerent model
from the NMR ensemble. For X-ray structures with reso-
lution better than 4.0A ˚ , we computed the anchor residues
from the most probable biological assembly predicted by
the European Bioinformatics Institute PISA service (27),
which has been reported to predict biological assemblies
with high accuracy (28). By using biological assemblies, we
intended to enrich the database with anchor residues from
biologically meaningful protein interfaces, as opposed to
crystallographic interfaces.
Only the residues bearing a minimal change of SASA
(SASA>0.5 A ˚ 2) or whose binding energy was estimated
to be less than  0.5kcal/mol were included on the
database. All other residues were discarded. We intention-
ally set such low thresholds for SASA and energy in
order to allow maximum user ﬂexibility in querying the
database, while avoiding overloading it with millions of
non-interacting residues. On the construction of the
database, we used the software’s default behavior of
treating each individual chain in a PDB ﬁle as an individ-
ual protein, thus the values of SASA and energy
recorded on the database correspond to the interaction
of each individual chain against all the others.
The ANCHOR database is stored and indexed by
MySQL (http://www.mysql.com), a relational database
system. The user may query for anchor residues in PPIs
by attributes such as PDB ID, residue type, SASA,
energy and/or keywords from the PDB ﬁle (Figure 1).
To process keyword queries, ANCHOR uses a web
service API (Application Programming Interface) to ﬁrst
obtain online from the RCSB PDB servers (http://www
.pdb.org) a list of PDB entries satisfying the given
keyword query. Then, without any user intervention,
ANCHOR returns all anchor residues from those PDB
entries and satisfying the remaining attributes of the
query (if applicable). Because keyword queries are in
fact processed on-demand by RCSB PDB, ANCHOR
inherits all its complex keyword query features, such as
support for logical operators, grouping terms, wildcard,
etc. For example, the following is a valid keyword query
accepted by ANCHOR (taken from the RCSB PDB
Figure 1. ANCHOR database. Front page of the search engine.
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cell death’).
An example of the output of a query is shown in
Figure 2. It consists of a list of PDB codes, chain ids,
residue name and number, the amount of solvent access-
ible surface area buried by the side chain (SASA) both in
A ˚ 2 and as percentage relative to the SASA of the
side-chain in the free tri-peptide Ala-Res-Ala. The list
also includes an empirical estimate of the residue contri-
bution to the binding free energy, keywords from the
PDB, and PDB title.
Visualization tool
The visualization tool is based on Jmol (http://www.jmol
.org) and needs the Java Virtual Machine (JVM) to be
pre-installed in the host computer (Figure 3). The inter-
active tool appears as a new window that includes visual-
ization options as well as a table with all the interface
residues of the selected chain sorted according to
SASA. Any of the residues listed in the table can be
selected in order to visually inspect its chemical comple-
mentarity on the acceptor protein. The anchor is displayed
as sticks (default), and the acceptor protein as a solvent
accessible surface (default). Surface options such as mo-
lecular surface or cavities, color codes based on partial
charges (default) or B-factors, transparency and environ-
ment are available to the display mode. Other options
such as atom representation, display, color scheme, and
labels are applied to a selection before placing on view
(‘apply to’ option). The user can further display other
residues from the table by clicking the appropriate
residue number, or select the environment option to
expand the view of the anchor to residues within 6, 8, 10
and 12A ˚ or the whole protein. Other settings include:
hydrogen bonds shown with a dashed line, zooming in
around a residue, and secondary structures shown in
cartoon representation.
UTILITY AND DISCUSSION
Analysis of PPI hotspots for drug discovery
In order for a small molecule to bind with high aﬃnity to a
given protein target, the molecule ideally needs to bury a
substantial fraction of its surface area into the protein
surface. For enzymes and small molecule receptors, this
is typically accomplished by targeting the large cavities
present on the surface of those proteins (4). However,
for PPI targets, which are often devoid of such large
cavities, the burial of large amounts of surface area can
be achieved by simultaneously targeting the sites of two or
more anchor residues lying in close proximity to each
other. This suggestion is corroborated by the observation
made by Fuller and colleagues (29) that PPIs and PPI
inhibitors tend to occupy simultaneously several
average-sized pockets. Intuitively, the larger the number
of anchor residues and their associated SASA more
‘druggable’ is the protein interface with a natural molecu-
lar weight limit for small molecular weight inhibitors.
As an example, Figure 3 (anchor visualization tool)
shows the interaction between MDM2 (surface represen-
tation) and three anchor residues from p53 (stick repre-
sentation). These three residues are among those with the
Figure 2. Typical outcome of search of PPIs in PDB. Example displays entries with a Trp anchor residue contributing less than (FastContact)
 5kcal/mol towards the binding free energy and associated with the keyword ‘oncogene’. Search resulted in 19 Trp residues from 15 PDBs.
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binding interaction energy. Note that the table of interact-
ing residues also show the C-terminal ASN29 as having a
large value of SASA and unfavorable predicted energy
(+3.7kcal/mol) due to the extra COO
  group. Thus, as is,
ASN29 is not a good group to target for drug design. On
the other hand, the three selected residues (PHE19, TRP23
and LEU26) are indeed hotspot anchors that have been
exploited on the design of compounds that bind to
MDM2 (29).
Anchors versus hot-spots
It is interesting to note that although ‘anchors’ are often
‘hot-spots’, a simple screening of the ANCHOR database
using the SASA and Energy options shows that there are
many residues with almost no buried area but strong inter-
action energies (‘hot-spots’), as well as residues with large
buried areas and little or no interaction energies
(‘anchors’). Although energy estimates are bound to
include some false predictions, our visualization tool
clearly identiﬁes plenty of potential hot-spots with little
or no value as primary target sites due to their superﬁcial
contact (often forming hydrogen bonds). The opposite is
not necessarily true for deeply buried residues, since
rational modiﬁcations might be able to improve the
chemical aﬃnity towards the anchor cavity.
Anchor-based drug design
Because anchor side chains play a crucial role in molecular
recognition by burying large amounts of solvent-accessible
surface area into the acceptor protein (9,10), side-chain
analogs of anchor residues are ideal fragments to incorp-
orate in structure-based design of compounds that might
interfere with PPIs. Moreover, since there is good evidence
that in many cases the anchoring grooves are relatively
unchanged upon complexation, they constitute a
uniquely well-characterized site for docking small mol-
ecules. This means that anchor analogs incorporated
into compounds have by design a great propensity to ﬁll
well-deﬁned pockets in the acceptor protein.
Screening protein–protein interfaces for small molecule
intervention
By using deeply buried anchor side chains as a surrogate
for druggable binding sites, ANCHOR database and
associated query engine can be used to screen for PPIs
suitable for small molecule intervention. For example,
Figure 2 shows the outcome of a search for Trp anchors
with FastContact binding energy less than  5.0kcal/mol
from PPIs entries associated with the keyword ‘oncogene’.
The search results in 19 Trp residues from 15 PDB entries.
Out of these 15 entries, 14 entries are anti-cancer PPI
targets, namely: eight related structures of MDM2 and
MDMX bound to p53 and short peptides; ﬁve related
structures of CDK4 bound to cyclin D1 and cyclin D3;
and one structure of Smad4 bound to Ski. This example
highlights the potential of ANCHOR to ﬁnding relevant
PPI targets for small molecule intervention.
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Figure 3. Visualization tool showing anchor residues Phe19, Trp23 and Leu26 of p53 from PDB 1YCR (PPI: p53-MDM2).
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